Compare Clinical Laserthermia Systems AB with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
SEK 168 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.31
-60.35%
2.41
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Dec 2025)
Net Profit:
-12 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-33.43%
0%
-33.43%
6 Months
-49.24%
0%
-49.24%
1 Year
61.81%
0%
61.81%
2 Years
-68.09%
0%
-68.09%
3 Years
245.19%
0%
245.19%
4 Years
32.39%
0%
32.39%
5 Years
16.21%
0%
16.21%
Clinical Laserthermia Systems AB for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
66.42%
EBIT Growth (5y)
7.33%
EBIT to Interest (avg)
-28.36
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.38
Sales to Capital Employed (avg)
0.27
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.06
EV to EBIT
-5.40
EV to EBITDA
-5.84
EV to Capital Employed
3.71
EV to Sales
7.95
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-68.65%
ROE (Latest)
-64.37%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
0.80
4.60
-82.61%
Operating Profit (PBDIT) excl Other Income
-10.10
-14.20
28.87%
Interest
0.10
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-12.30
-8.70
-41.38%
Operating Profit Margin (Excl OI)
-13,055.40%
-3,261.90%
-979.35%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is -82.61% vs 2.22% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is -41.38% vs 66.02% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
17.50
18.80
-6.91%
Operating Profit (PBDIT) excl Other Income
-26.40
-51.60
48.84%
Interest
0.20
0.40
-50.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-42.00
-47.90
12.32%
Operating Profit Margin (Excl OI)
-1,658.10%
-2,890.50%
123.24%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -6.91% vs 126.51% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 12.32% vs 40.79% in Dec 2024
About Clinical Laserthermia Systems AB 
Clinical Laserthermia Systems AB
Pharmaceuticals & Biotechnology
Clinical Laserthermia Systems AB is a Sweden-based company active in the medical equipment industry. The Company develops and markets a product for the treatment of solid cancer tumors. The product is based on Immunostimulating Laser Thermo Therapy (imILT). imILT method can be used for all tumors in solid organ and the potential market is considerable. Examples of tumors which are suitable for treatment are those found in liver, breast, lung, prostate, kidney, pancreas and thyroid. Clinical Laserthermia Systems AB's treatment system consists of two main parts: a mobile laser device and a sterile patient unit for single use. The Company's product is intended for medical professionals within surgical oncology or interventional radiology within oncology. In April 2014, the Company announced the establishment of a subsidiary in the United States.
Company Coordinates 
Company Details
Medicon Village, Scheelevagen 2 , LUND None : 223 81
Registrar Details






